Conmed Corp (CNMD) Files Form 4 Insider Selling : Luke A Pomilio Sells 4,400 Shares

Conmed Corp (CNMD): Luke A Pomilio , EVP, Finance & CFO of Conmed Corp sold 4,400 shares on Jun 3, 2016. The Insider selling transaction was reported by the company on Jun 6, 2016 to the Securities and Exchange Commission. The shares were sold at $41.56 per share for a total value of $182,880.72 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Apr 4, 2016, Charles Farkas (director) purchased 338 shares at $42.05 per share price.On Mar 7, 2016, Mark D Snyder (EVP Mfg. Ops & Business System) sold 2,940 shares at $41.32 per share price.Also, On Mar 3, 2016, John L Workman (director) purchased 2,500 shares at $39.85 per share price.On Feb 19, 2016, Jerome J. Lande (director) sold 1,630,800 shares at $38.28 per share price.

Shares of CONMED Corporation (CNMD) ended Friday, Jun 3, 2016 session in red amid volatile trading. The shares closed down -0.36 points or -0.85% at $41.83 with 1,24,124 shares getting traded. Post opening the session at $42.14, the shares hit an intraday low of $41.46 and an intraday high of $42.14 and the price vacillated in this range throughout the day. The company has a market cap of $1,161 M and the number of outstanding shares has been calculated to be 2,77,51,474 shares. The 52-week high of CONMED Corporation is $60.662 and the 52-week low is $35.51.

CONMED Corporation Money Flow Index Chart

On May 25, 2016, CONMED Corporation announced a cash dividend of $0.2000. The company’s management has announced Jun 13, 2016 as the ex-dividend date and fixed the record date on Jun 15, 2016. The payable date has been fixed on Jul 6, 2016.

Company has been under the radar of several Street Analysts.CONMED Corporation is Reiterated by Needham to Buy and the brokerage firm has raised the Price Target to $ 49 from a previous price target of $48 .The Rating was issued on Apr 28, 2016.

CONMED Corporation is a medical technology company. The Company is engaged in the development manufacturing and sale on a global basis of surgical devices and related equipment. The Company’s products are used by surgeons and physicians in a variety of specialties including orthopedics general surgery gynecology neurosurgery and gastroenterology. Its product lines consist of orthopedic surgery general surgery and surgical visualization. Orthopedic surgery consists of sports medicine instrumentation and small bone large bone and specialty powered surgical instruments. General surgery consists of a line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures a line of cardiac monitoring products as well as electrosurgical generators and related instruments. Surgical visualization consists of 2D and 3D video systems for use in minimally invasive orthopedic and general surgery.

Leave a Reply

CONMED Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on CONMED Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.